GSE123740
SUM52PE treated with PI3K-mTOR inhibitors
PI3K/mTOR inhibition alters gene transcription signatures involved in metabolism and cell cycle control in the human breast cancer cell line, SUM52PE Overall design: SUM52PE cells were cultured in triplicate for 72h with the P13K/mTOR inhibitors dactolisib, everolimus, AZD-8055 or buparlisib, before RNA was isolated and submitted for RNA-Seq